Abstract
The tumor suppressor BRCA1-associated protein 1 (BAP1) is frequently mutated in uveal melanoma, where its loss is associated with poor prognosis. Although BAP1 has been implicated in homologous recombination (HR), its role in non-homologous end-joining (NHEJ) remains poorly defined. Here, we show that BAP1 functions as a central regulator of DNA double-strand break (DSB) repair by coordinating HR and NHEJ. BAP1 depletion disrupts recruitment and activity of the NHEJ machinery. Mechanistically, this defect is driven by aberrant accumulation of H2AK119-ub at DSB sites, promoting excessive DNA end resection and suppressing NHEJ activation. Importantly, inhibition of DNA end resection or suppression of H2AK119-ub restores NHEJ factor recruitment, establishing a causal link between BAP1-regulated histone modifications and repair pathway choice. Clinically, BAP1 loss correlates with genomic instability, providing a mechanistic basis for its association with poor outcomes in uveal melanoma. Collectively, these findings identify BAP1 as a gatekeeper of DSB repair fidelity, revealing a previously unrecognized role in safeguarding NHEJ and maintaining balanced DNA repair.
Full text
1,584 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
The tumor suppressor BRCA1-associated protein 1 (BAP1) is frequently mutated in uveal melanoma, where its loss is associated with poor prognosis. Although BAP1 has been implicated in homologous recombination (HR), its role in non-homologous end-joining (NHEJ) remains poorly defined. Here, we show that BAP1 functions as a central regulator of DNA double-strand break (DSB) repair by coordinating HR and NHEJ. BAP1 depletion disrupts recruitment and activity of the NHEJ machinery. Mechanistically, this defect is driven by aberrant accumulation of H2AK119-ub at DSB sites, promoting excessive DNA end resection and suppressing NHEJ activation. Importantly, inhibition of DNA end resection or suppression of H2AK119-ub restores NHEJ factor recruitment, establishing a causal link between BAP1-regulated histone modifications and repair pathway choice. Clinically, BAP1 loss correlates with genomic instability, providing a mechanistic basis for its association with poor outcomes in uveal melanoma. Collectively, these findings identify BAP1 as a gatekeeper of DSB repair fidelity, revealing a previously unrecognized role in safeguarding NHEJ and maintaining balanced DNA repair.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
This version of the manuscript includes new experimental data and expanded analyses that strengthen the main findings and establish clear causal relationships. Figures have been revised to incorporate the new data, and the manuscript has been reorganized to improve clarity and presentation of the results.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.